Home › All Companies › TLSIW › Current Report

TriSalus Life Sciences, Inc. (TLSIW) — Current Report

AI-Powered SEC Filing Analysis

← All TLSIW filings
Latest Current Report Filed: 2026-04-07

Key Insights

  • TriSalus Life Sciences, Inc. has appointed Dr. Richard Marshall as its new Chief Medical Officer, effective June 29, 2026.
  • Dr. Marshall will receive an annual base salary of $525,000 and a sign-on bonus of $250,000, along with eligibility for an annual bonus of up to 50% of his base salary.
  • The company will grant Dr. Marshall 120,000 stock options and 60,000 restricted stock units, as well as eligibility for annual equity grants under the company's Equity Incentive Plan.
Sentiment: Positive Significance: 6/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-04-07. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.